This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Viral Infections  • Pathology of Head & Neck  • Otolaryngology/ Head & Neck Surgery, Other  • Pediatrics  • Pediatrics, Other  • Transplantation, Other  • Immunology  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

Sarah E. Mowry, MD; Ali M. Strocker, MD; Jessica Chan, MD; Christopher Takehana, BS; Nader Kalantar, MD; Sunita Bhuta, MD; Nina L. Shapiro, MD

Arch Otolaryngol Head Neck Surg. 2008;134(9):936-939.

Objective  To compare lymphocyte immunohistochemical markers and staining for Epstein-Barr virus (EBV) in tonsillectomy specimens from healthy children and pediatric transplant recipients.

Design  Analysis of pathology specimens.

Setting  Tertiary care medical center.

Patients  Consecutive sample of tonsillectomy specimens from 60 pediatric solid organ transplant recipients and 60 healthy children.

Intervention  Immunohistochemical staining of tonsillectomy specimens for and light chains, B and T lymphocytes, EBV-encoded small nuclear RNA (EBV-EBER), and EBV-encoded latent membrane protein (EBV-LMP).

Main Outcome Measure  Detection of a difference in EBV activity in transplant recipients vs healthy controls.

Results  There was 1 case of posttransplantation lymphoproliferative disorder (PTLD). All other tonsillectomy specimens from both groups demonstrated follicular hyperplasia. Tonsillectomy specimens from both groups were polyclonal, expressing and light-chain activity, including the case of PTLD. The number of specimens staining positive for CD3 activity, a marker of T lymphocytes, was reduced in the transplant group (85%), compared with 100% in the control group (P < .01). EBV-EBER is a nuclear stain indicating active EBV infection, whereas EBV-LMP staining denotes latent infection. Twenty-seven of 60 transplant specimens (45%) demonstrated EBV-EBER activity compared with 0 of 60 control specimens (P < .001). EBV-LMP activity was equal in both groups.

Conclusions  Adenotonsillar hypertrophy in transplant recipients with no prior exposure to EBV may be a sign of active EBV infection. A high incidence of EBV-EBER was found in the tonsils of transplant recipients. Active adenotonsillar EBV infection in the setting of T-lymphocyte suppression in transplant recipients may be a potential early precursor of PTLD.

Author Affiliations: Division of Otolaryngology–Head and Neck Surgery (Drs Mowry, Strocker, Kalantar, and Shapiro and Mr Takehana) and Department of Pathology and Laboratory Medicine (Drs Chan and Bhuta), David Geffen School of Medicine, University of California, Los Angeles.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?